Results 11 to 20 of about 87,371,428 (168)

Use and Outcomes of Medication for Opioid Use Disorder Among Patients With Opioid Use Disorder Undergoing Surgery

Annals of Surgery Open
Objective:. We examined patterns of use of perioperative medication for opioid use disorder (MOUD) in patients undergoing surgical procedures and assessed the association between MOUD use and perioperative opioid use and postsurgical adverse events ...
Alicia H. Li, MD, Yongmei Huang, MD, DrPH, Silvia S. Martins, MD, PhD, Yukio Suzuki, MD, PhD, Jennifer S. Ferris, PhD, Xiao Xu, PhD, Dawn L. Hershman, MD, Jason D. Wright, MD   +7 more
doaj   +2 more sources

Patient centered medication treatment for opioid use disorder in rural Vermont: a qualitative study

Addiction Science & Clinical Practice
Background Opioid-related fatal overdoses are occurring at historically high levels and increasing each year. Accessible social and financial support are imperative to the initiation and success of treatment for Opioid Use Disorder (OUD). Medications for
Emily G. Hichborn, Owen B. Murray, Eilis I. Murphy, Tess E. Gallant, Sarah K. Moore, Bethany M. McLeman, John Saroyan, Anthony Folland, Megan Mitchell, Lisa A. Marsch   +9 more
doaj   +2 more sources

Impact of a National Stepped-Care Model of Opioid Use Disorder Treatment on Access to Medication Therapies Among Homeless-Experienced Veterans. [PDF]

Health Serv Res
ABSTRACT Objective To determine whether the Veterans Health Administration's (VHA) Stepped Care for Opioid Use Disorder Train‐the‐Trainer (SCOUTT) initiative increased medication treatment for opioid use disorder (MOUD) among persons experiencing homelessness (PEH).
Li H, Baylis JD, Huebler S, Gordon AJ, Hawkins E, Hagedorn HJ, Kertesz SG, Suo Y, Zhang Y, Jones AL.   +9 more
europepmc   +2 more sources

A Systematic Review Examining Patient and Provider Attitudes Toward Use of Medication for Opioid Use Disorder [paper] [PDF]

, 2023
School of Nursing CapstonesIntroduction: Despite drastically rising rates of opioid overdose related deaths, rigid opinions of both patients and providers against the use of medication for opioid use disorder persist in the face of well-established ...
Trejo, Anyssa
core   +1 more source

Conceptual model for effects of three methods of medication for opioid use disorder (MOUD) induction on long-term maintenance treatment.

, 2023
Conceptual model for effects of three methods of medication for opioid use disorder (MOUD) induction on long-term maintenance treatment.
Donald E. Nease Jr. (16954513), Maret Felzien (16954522), David Wolff (3506819), Ben Sofie (16954516), Linda Zittleman (16954525), L. Miriam Dickinson (8852369), Cory Lutgen (6868019), Lori Heeren (16954519), Douglas H. Fernald (16954510), John M. Westfall (10955511), Bethany M. Kwan (7921289), Jennifer K. Carroll (13770173)   +11 more
core   +1 more source

A randomized, sham-controlled, quintuple-blinded trial to evaluate the NET device as an alternative to medication for promoting opioid abstinence

Contemporary Clinical Trials Communications, 2022
Background: There is an unmet need for non-medication approaches to illicit opioid discontinuation and relapse prevention. The NET (NeuroElectric Therapy) Device is a non-invasive, battery-operated, portable, re-useable device designed to deliver ...
Mark K. Greenwald, Samiran Ghosh, Joe R. Winston   +2 more
doaj   +1 more source

Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone [PDF]

Mental Health Clinician, 2021
Introduction: Physician-pharmacist collaborative practice models (PPCPM) decrease barriers and increase access to medications for opioid use disorder (MOUD) but are not routine in practice. The purpose of this quality improvement initiative is to develop
Lindsay M. Mailloux, PharmD, Matthew T. Haas, PharmD, BCPP, BCPS, Janel M. Larew, PharmD, BCPS, Beth M. DeJongh, PharmD, BCPP, BCPS   +3 more
doaj   +1 more source

Methadone Versus Buprenorphine/Naloxone: Treatment Outcome Differences Among Individuals Receiving Medications for Opioid Use Disorders in Rural Treatment Settings-A 1-Year Retrospective Cohort Study. [PDF]

J Rural Health
ABSTRACT Background Medication for opioid use disorder (MOUD) is the gold standard of treatment for opioid use disorder (OUD). Methadone and buprenorphine have shown to be the most effective MOUD, yet little is known about the compared efficacy when treating OUD in community‐based rural treatment settings.
MacCamy A, Khairy L, Wasser T, Gill G, Kenefick L, Schmidt A, Akana N, Hall L, Kwon K, Limberg N, Kirk-Lewis K, Lewis M, Owen M, McPherson SM, Miguel AQ.   +14 more
europepmc   +2 more sources

Smartphone intervention to optimize medication-assisted treatment outcomes for opioid use disorder: study protocol for a randomized controlled trial

Trials, 2023
Background Opioids accounted for 75% of drug overdoses in the USA in 2020, with rural states particularly impacted by the opioid crisis. While medication-assisted treatment (MAT) with Suboxone remains one of the more efficacious treatments for opioid use
Ronald G. Thompson, Mary Bollinger, Michael J. Mancino, Deborah Hasin, Xiaotong Han, Keith A. Bush, Clint D. Kilts, G. Andrew James   +7 more
doaj   +1 more source

Initiation of medication for opioid use disorder across a health system: A retrospective analysis of patient characteristics and inpatient outcomes

Drug and Alcohol Dependence Reports, 2022
Objectives: Medication for opioid use disorder (MOUD) has gained significant momentum as an evidence-based intervention for treating opioid use disorder (OUD).
Brian P. O'Rourke, Tory H. Hogan, Julie Teater, Martin Fried, Margaret Williams, Alison Miller, Aaron D. Clark, Phuong Huynh, Emily Kauffman, Jennifer L. Hefner   +9 more
doaj   +1 more source